United States · Who invested in Aperion Biologics?
Aperion Biologics's investors include Hasso Plattner Ventures.
20122013
$4.5MVenture$940KSeries DUnited States · Series D startup
Who invested in Aperion Biologics
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.4Mraised across 2 rounds since 2011, from 2 sources
$4.5MVenture$940KSeries D
- Latest round
- Series D, $940KFeb 2013
- Biggest round
- $4.5MVenture · May 2011
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $4.5M May 2011
- Biggest round
- $4.5M Venture · May 2011
- Between rounds
- 20 months from the last two
The rounds
- Feb 2013
- May 2011Venture$4.5M
No investor was named in the report.
Reported by sec.govSEC filing: $4.5M sold, first sale May 2011
Quick answers about Aperion Biologics
How much has Aperion Biologics raised?
Aperion Biologics has raised $5.4M across 2 rounds since 2011.
When did Aperion Biologics last raise?
Aperion Biologics's most recent round was a Series D of $940K in Feb 2013.
What was Aperion Biologics's biggest round?
Aperion Biologics's largest round on record is $4.5M (Venture), in May 2011.
Who backed Aperion Biologics first?
Aperion Biologics's first round on record, in Feb 2013, was backed by Hasso Plattner Ventures.
What stage is Aperion Biologics at?
Aperion Biologics's latest named round is a Series D, in Feb 2013.
Where is Aperion Biologics based?
Aperion Biologics is based in the United States.
Companies like Aperion Biologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.